ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call
Rhea-AI Summary
ICU Medical (Nasdaq: ICUI) announced the timing for its fourth quarter 2025 earnings release and conference call. Results will be released on Thursday, February 19, 2026 at ~4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET.
The call is accessible by phone (800-274-8461, conference ID “ICUMED”) and by webcast via the company website under Investors; a replay will be available.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
ICUI was down 0.47% while peers were mixed: WRBY -1.38%, MMSI -1.53%, but NVST +1.72%, XRAY +3.73%, TFX +2.97%, indicating stock-specific trading rather than a unified sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 31 | Conference presentation | Neutral | -1.4% | Announcement of presentation at J.P. Morgan Healthcare Conference with webcast access. |
| Nov 20 | Conference participation | Neutral | +1.3% | Participation in Piper Sandler healthcare conference and webcast fireside chat. |
| Nov 06 | Earnings and guidance | Positive | +1.8% | Q3 2025 results with improved margins and raised FY2025 guidance. |
| Oct 23 | Earnings call timing | Neutral | -0.6% | Announcement of Q3 2025 earnings release date and conference call details. |
| Aug 21 | Investor conferences | Neutral | -1.3% | Planned participation in two September 2025 healthcare investor conferences. |
Recent conference and scheduling announcements have led to modest, mixed price moves, while the last earnings/guidance update saw a positive reaction.
Over the past six months, ICU Medical has mainly issued conference and event updates alongside a key earnings release. On Nov 6, 2025, the company reported Q3 2025 results and raised FY2025 guidance, with shares rising 1.8%. Multiple investor conference appearances in August–December 2025 saw small positive and negative moves around ±1–1.3%. A prior earnings call timing announcement on Oct 23, 2025 coincided with a -0.56% move, suggesting earnings date notices themselves have had limited directional impact.
Market Pulse Summary
This announcement sets the timetable for ICU Medical’s fourth quarter 2025 results, with the release at 4:00 p.m. ET and a conference call at 4:30 p.m. ET on February 19, 2026. It follows Q3 2025 results where guidance was raised and the stock moved 1.8%. Investors may focus on how upcoming numbers compare with prior guidance and past quarterly trends, using the scheduled call and webcast to assess operating performance and any strategic updates.
AI-generated analysis. Not financial advice.
SAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2025 earnings release and conference call.
The Company will release its fourth quarter 2025 results on Thursday, February 19, 2026 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, February 19, 2026. The call can be accessed at (800) 274-8461, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.